In summary, our results demonstrated that MSCs treatment attenuates hyperglycemia-induced endothelial injury through the mitophagy-mediated removal of dysfunctional mitochondria, in which the Pink1/Parkin pathway plays a critical role. The gene discussed is PINK1; the disease is Hyperglycemia.